Stay updated with breaking news from Punit Dhillon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Financing expected to fund strategic expansion of obesity clinical development and extend operating runway beyond 2026San Diego, California--(News...
Skye Bioscience, Inc. , a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid...
Financing co-led by a leading life science investor and 5AM Ventures expected to fully fund obesity Phase 2 trial assessing nimacimab, Skye's diff...
San Diego, California--(Newsfile Corp. - January 29, 2024) - Skye Bioscience, Inc. (OTCQB: SKYE) ('the Company'), a clinical stage
Breaking Biotech Funding News - Skye Bioscience (OTCQB: SKYE) Announces $50.25 Million Private Placement Equity Financing